CIK 0001087294
- Non-accelerated filer
- Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- Operating
- EIN
- 621765329
- Phone
- +1 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-18 | Hamm John M. VP Chief Financial Officer | Grant or award · Options (right to buy) | +3,000 | $2.80 | $8K | 18,250 |
| 2025-03-17 | Hamm John M. VP Chief Financial Officer | Grant or award · Options (right to buy) | +2,750 | $5.17 | $14K | 15,250 |
| 2025-03-16 | Hamm John M. VP Chief Financial Officer | Shares withheld for taxes | −5,930 | $5.46 | $32K | 20,073 |
| 2024-03-25 | Hamm John M. VP Chief Financial Officer | Grant or award · Options (right to buy) | +5,500 | $1.71 | $9K | 12,500 |
| 2024-03-23 | Hamm John M. VP Chief Financial Officer | Shares withheld for taxes | −445 | $1.81 | $805 | 26,003 |
| 2023-11-27 | Hamm John M. Chief Financial Officer | Shares withheld for taxes | −352 | $1.67 | $588 | 26,448 |
| 2023-03-24 | Hamm John M. Chief Financial Officer | Grant or award · Options (right to buy) | +2,000 | 7,000 | ||
| 2022-03-16 | Hamm John M. Chief Financial Officer | Grant or award | +20,000 | $2.59 | $52K | 26,800 |
| 2022-03-16 | Hamm John M. Chief Financial Officer | Grant or award · Options (right to buy) | +2,000 | 2,000 | ||
| 2021-11-23 | Hamm John M. Chief Financial Officer | Purchase | +3,800 | $2.35 | $9K | 6,800 |
Page 1 of 1 · 10 trades